Finance

Beta
Lists
PVLA:NASDAQ
Palvella Therapeutics Inc
$148.21
+8.82%
(+12.01) 1D
$148.21
-0.00% (-0.0027)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVLA...
Open
$135.32
High
$149.39
Low
$134.41
Mkt. cap
2.13B
Avg. vol.
249.93K
Volume
1.17M
52-wk high
$151.18
52-wk low
$20.35
EPS
-$4.16
Beta
-0.14
Shares outstanding
14.34M
No. of employees
29
Open
$135.32
High
$149.39
Low
$134.41
Mkt. cap
2.13B
Avg. vol.
249.93K
Volume
1.17M
52-wk high
$151.18
52-wk low
$20.35
EPS
-$4.16
Beta
-0.14
Shares outstanding
14.34M
No. of employees
29
News stories
From sources across the web
About Palvella Therapeutics Inc
CEO-
Employees29
Founded-
Headquarters-
SectorBiotechnology
Websitepalvellatx.com
Analyst ratings
Based on 12 analysts giving stock ratings to PVLA in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for PVLA in the last 3 months.
Highest
Current $148.21
$270.00 (+82.17%)
Average
$233.55 (+57.58%)
Lowest
$205.00 (+38.32%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Reiterated
$227.00
+53.2%
06/25/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$250.00
+68.7%
06/24/2026
Albert Lowe
Craig-Hallum
Buy
Reiterated
$205.00
+38.3%
06/22/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
$270.00
+82.2%
06/11/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$240.00
+61.9%
06/04/2026
Danielle Brill
Truist Financial
Buy
Maintained
-
-
05/21/2026
Trevor Allred
Oppenheimer
Buy
Reiterated
$210.00
+41.7%
05/21/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$240.00
+61.9%
05/20/2026
Sudan Loganathan
Stephens
Buy
Initiated
$220.00
+48.4%
05/11/2026
Ritu Baral
TD Cowen
Buy
Maintained
$267.00
+80.1%
05/08/2026
Sam Slutsky
LifeSci Capital
Buy
Reiterated
$225.00
+51.8%
05/09/2026
Jeet Mukherjee
BTIG
Buy
Reiterated
$215.00
+45.1%
04/01/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
$220.00
+48.4%
03/02/2026
Catherine Novack
JonesTrading
Buy
Maintained
$209.00
+41%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.12M
6.53M
7.12M
9.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.13M
3.65M
4.18M
5.52M
Operating expense
9.25M
10.18M
11.30M
14.86M
Total operating expenses
9.25M
10.18M
11.30M
14.86M
Operating income
-9.25M
-10.18M
-11.30M
-14.86M
Other non operating income
443.00K
-286.00K
-191.00K
54.00K
EBT including unusual items
-9.47M
-11.34M
-12.71M
-15.77M
EBT excluding unusual items
-9.47M
-11.34M
-12.71M
-15.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.47M
-11.34M
-12.71M
-15.77M
Net profit margin
-
-
-
-
Earnings per share
-0.86
-1.03
-1.08
-1.20
Interest and investment income
690.00K
628.00K
520.00K
1.07M
Interest expense
-1.35M
-1.51M
-1.74M
-2.04M
Net interest expenses
-664.00K
-882.00K
-1.22M
-966.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of PVLA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer